The DOI matches its Crossref record; 116 of the 120 references it cites were found in a registry or an index.
RosettaAntibodyDesign (RAbD): A general framework for computational antibody design
Open accessPublished version of a preprint
Abstract
A structural-bioinformatics-based computational methodology and framework have been developed for the design of antibodies to targets of interest. RosettaAntibodyDesign (RAbD) samples the diverse sequence, structure, and binding space of an antibody to an antigen in highly customizable protocols for the design of antibodies in a broad range of applications. The program samples antibody sequences and structures by grafting structures from a widely accepted set of the canonical clusters of CDRs (North et al., J. Mol. Biol., 406:228-256, 2011). It then performs sequence design according to amino acid sequence profiles of each cluster, and samples CDR backbones using a flexible-backbone design protocol incorporating cluster-based CDR constraints. Starting from an existing experimental or computationally modeled antigen-antibody structure, RAbD can be used to redesign a single CDR or multiple CDRs with loops of different length, conformation, and sequence. We rigorously benchmarked RAbD on a set of 60 diverse antibody-antigen complexes, using two design strategies-optimizing total Rosetta energy and optimizing interface energy alone. We utilized two novel metrics for measuring success in computational protein design. The design risk ratio (DRR) is equal to the frequency of recovery of native CDR lengths and clusters divided by the frequency of sampling of those features during the Monte Carlo design procedure. Ratios greater than 1.0 indicate that the design process is picking out the native more frequently than expected from their sampled rate. We achieved DRRs for the non-H3 CDRs of between 2.4 and 4.0. The antigen risk ratio (ARR) is the ratio of frequencies of the native amino acid types, CDR lengths, and clusters in the output decoys for simulations performed in the presence and absence of the antigen. For CDRs, we achieved cluster ARRs as high as 2.5 for L1 and 1.5 for H2. For sequence design simulations without CDR grafting, the overall recovery for the native amino acid types for residues that contact the antigen in the native structures was 72% in simulations performed in the presence of the antigen and 48% in simulations performed without the antigen, for an ARR of 1.5. For the non-contacting residues, the ARR was 1.08. This shows that the sequence profiles are able to maintain the amino acid types of these conserved, buried sites, while recovery of the exposed, contacting residues requires the presence of the antigen-antibody interface. We tested RAbD experimentally on both a lambda and kappa antibody-antigen complex, successfully improving their affinities 10 to 50 fold by replacing individual CDRs of the native antibody with new CDR lengths and clusters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RosettaAntibodyDesign (RAbD) [89] relies on two algorithmic loops referred to the outer and inner loops of design.”
From Computational and artificial intelligence-based methods for antibody development (2023) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gentleman R: R: A language for data analysis and graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,747
Amino acid substitution matrices from protein blocks.
Henikoff, S., & Henikoff, J. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10915 · Cited by 6,218
R: A Language for Data Analysis and Graphics
Ihaka, R., & Gentleman, R. C. (1996) · Journal of Computational and Graphical Statistics · doi:10.2307/1390807 · Cited by 4,245
Smith, G. P. (1985) · Science · doi:10.1126/science.4001944 · Cited by 4,143
Phage antibodies: filamentous phage displaying antibody variable domains
McCafferty, J., Griffiths, A. D., Winter, G. P., & Chiswell, D. J. (1990) · Nature · doi:10.1038/348552a0 · Cited by 2,427
Engineered antibody fragments and the rise of single domains
Holliger, P., & Hudson, P. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1142 · Cited by 1,928
Design of a Novel Globular Protein Fold with Atomic-Level Accuracy
Kuhlman, B. A., Dantas, G. A., Ireton, G. C., Varani, G., Stoddard, B. L., & Baker, D. A. (2003) · Science · doi:10.1126/science.1089427 · Cited by 1,666
Making antibodies by phage display technology
Winter, G., Griffiths, A. D., Hawkins, R. E., & Hoogenboom, H. R. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.002245 · Cited by 1,573
The Rosetta All-Atom Energy Function for Macromolecular Modeling and Design
Alford, R. F., Leaver-Fay, A., Jeliazkov, J. R., O’Meara, M. J., DiMaio, F. P., Park, H., Shapovalov, M. V., Renfrew, P. D., Mulligan, V. K., Kappel, K., et al. (2017) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.7b00125 · Cited by 1,532
Self-citationCanonical structures for the hypervariable regions of immunoglobulins
Chothia, C., & Lesk, A. M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90412-8 · Cited by 1,406
Flagged first, then by citations
4 of the 120 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Macromolecular modeling and design in Rosetta: recent methods and frameworks
Leman, J. K., Weitzner, B. D., Lewis, S. M., Adolf-Bryfogle, J., Alam, N., Alford, R. F., Aprahamian, M., Baker, D., Barlow, K. A., Barth, P., et al. (2020) · Nature Methods · doi:10.1038/s41592-020-0848-2 · Cited by 888
Self-citationAdvances in protein structure prediction and design
Kuhlman, B., & Bradley, P. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0163-x · Cited by 806
Fast, accurate antibody structure prediction from deep learning on massive set of natural antibodies
Ruffolo, J. A., Chu, L., Mahajan, S. P., & Gray, J. J. (2023) · Nature Communications · doi:10.1038/s41467-023-38063-x · Cited by 364
Computational approaches to therapeutic antibody design: established methods and emerging trends
Norman, R. A., Ambrosetti, F., Bonvin, A. M. J. J., Colwell, L. J., Kelm, S., Kumar, S., & Krawczyk, K. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbz095 · Cited by 219
“Since then, four methods have been made available: OptCDR [139], OptMAVEn[140], AbDesign [143] and RosettaAntibodyDesign [142].”
MethodComputational and artificial intelligence-based methods for antibody development
Kim, J., McFee, M., Fang, Q., Abdin, O., & Kim, P. M. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.12.005 · Cited by 178
Luo, S., Su, Y., Peng, X., Wang, S., Peng, J., & Ma, J. (2022) · doi:10.1101/2022.07.10.499510 · Cited by 151
Luo, S., Su, Y., Peng, J., Wang, S., Peng, J., & Ma, J. (2022) · neural information processing systems · doi:10.52202/068431-0709 · Cited by 170
Third generation antibody discovery methods: in silico rational design
Sormanni, P., Aprile, F. A., & Vendruscolo, M. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00523k · Cited by 143
Guest, J. D., Vreven, T., Zhou, J., Moal, I. H., Jeliazkov, J. R., Gray, J. J., Weng, Z., & Pierce, B. G. (2020) · Structure · doi:10.1016/j.str.2021.01.005 · Cited by 124
Advances in computational structure-based antibody design
Hummer, A. M., Abanades, B., & Deane, C. M. (2022) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2022.102379 · Cited by 109
DLAB-deep learning methods for structure-based virtual screening of antibodies
Schneider, C., Buchanan, A., Taddese, B., & Deane, C. M. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btab660 · Cited by 102
Qamar, M. T. U., Shokat, Z., Muneer, I., Ashfaq, U. A., Javed, H., Anwar, F., Bari, A., Zahid, B., & Saari, N. (2020) · Vaccines · doi:10.3390/vaccines8020288 · Cited by 100
Sifniotis, V., Cruz, E., Eroglu, B., & Kayser, V. (2019) · Antibodies · doi:10.3390/antib8020036 · Cited by 99
In vitro and in silico assessment of the developability of a designed monoclonal antibody library
Wolf Pérez, A.-M., Sormanni, P., Andersen, J. S., Sakhnini, L. I., Rodriguez-Leon, I., Bjelke, J. R., Gajhede, A. J., De Maria, L., Otzen, D. E., Vendruscolo, M., et al. (2019) · mAbs · doi:10.1080/19420862.2018.1556082 · Cited by 97
Solubility, Stability, and Avidity of Recombinant Antibody Fragments Expressed in Microorganisms
Kang, T. H., & Seong, B. L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01927 · Cited by 89
Iterative Refinement Graph Neural Network for Antibody Sequence-Structure Co-designPreprint
Jin, W., Wohlwend, J., Barzilay, R., & Jaakkola, T. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2110.04624 · Cited by 127
Wilman, W., Wróbel, S., Bielska, W., Deszyński, P., Dudzic, P., Jaszczyszyn, I., Kaniewski, J., Młokosiewicz, J., Rouyan, A., Satława, T., et al. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac267 · Cited by 86
A survey of geometric graph neural networks: data structures, models and applications
Han, J., Cen, J., Wu, L., Li, Z., Kong, X., Jiao, R., Yu, Z., Xu, T., Wu, F., Wang, Z., et al. (2025) · Frontiers of Computer Science · doi:10.1007/s11704-025-41426-w · Cited by 104
Guarra, F., & Colombo, G. (2023) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.3c00513 · Cited by 82
Toward Drug-Like Multispecific Antibodies by Design
Sawant, M. S., Streu, C. N., Wu, L., & Tessier, P. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207496 · Cited by 77
Tsai, Y.-X., Chang, N.-E., Reuter, K., Chang, H., Yang, T., von Bülow, S., Sehrawat, V., Zerrouki, N., Tuffery, M., Gecht, M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.01.034 · Cited by 76
Directed evolution methods for overcoming trade‐offs between protein activity and stability
Stimple, S. D., Smith, M. D., & Tessier, P. M. (2019) · AIChE Journal · doi:10.1002/aic.16814 · Cited by 67
Structure-informed Language Models Are Protein DesignersPreprint
Zheng, Z., Deng, Y., Xue, D., Zhou, Y., Ye, F., & Gu, Q. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.03.526917 · Cited by 72
A new era of antibody discovery: an in-depth review of AI-driven approaches
Cheng, J., Liang, T., Xie, X., Feng, Z., & Meng, L. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103984 · Cited by 63
Assessing human B cell repertoire diversity and convergence
Imkeller, K., & Wardemann, H. (2018) · Immunological Reviews · doi:10.1111/imr.12670 · Cited by 61
Dewaker, V., Morya, V. K., Kim, Y. H., Park, S. T., Kim, H. S., & Koh, Y. H. (2025) · Biomarker Research · doi:10.1186/s40364-025-00764-4 · Cited by 62
Engineering Stability, Viscosity, and Immunogenicity of Antibodies by Computational Design
Kuroda, D., & Tsumoto, K. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.01.011 · Cited by 59
Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design
Schoeder, C. T., Schmitz, S., Adolf‐Bryfogle, J., Sevy, A. M., Finn, J. A., Sauer, M. F., Bozhanova, N. G., Mueller, B. K., Sangha, A. K., Bonet, J., et al. (2021) · Biochemistry · doi:10.1021/acs.biochem.0c00912 · Cited by 57
Self-citationBai, G., Sun, C., Guo, Z., Wang, Y., Zeng, X., Su, Y., Zhao, Q., & Ma, B. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.06.005 · Cited by 57
Monoclonal antibodies: From magic bullet to precision weapon
Aboul-Ella, H., Gohar, A., Ali, A. A., Ismail, L. M., Mahmoud, A. E. E.-R., Elkhatib, W. F., & Aboul-Ella, H. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00210-1 · Cited by 66
OptMAVEn-2.0: De novo Design of Variable Antibody Regions against Targeted Antigen Epitopes
Chowdhury, R., Allan, M. F., & Maranas, C. D. (2018) · Antibodies · doi:10.3390/antib7030023 · Cited by 55
Antibody design using deep learning: from sequence and structure design to affinity maturation
Joubbi, S., Micheli, A., Milazzo, P., Maccari, G., Ciano, G., Cardamone, D., & Medini, D. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae307 · Cited by 56
mmCSM-AB: guiding rational antibody engineering through multiple point mutations
Myung, Y., Pires, D. E. V., & Ascher, D. B. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa389 · Cited by 51
Shimizu, I., Matsuyama, Y., Duvivier, R. J., & van der Vleuten, C. P. M. (2021) · BMC Medical Education · doi:10.1186/s12909-021-02667-y · Cited by 48
Li, J., Kang, G., Wang, J., Yuan, H., Wu, Y., Meng, S., Wang, P., Zhang, M., Wang, Y., Feng, Y., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125733 · Cited by 50
Quantifying the nativeness of antibody sequences using long short-term memory networks
Wollacott, A. M., Xue, C., Qin, Q., Hua, J., Bohnuud, T., Viswanathan, K., & Kolachalama, V. B. (2019) · Protein Engineering Design and Selection · doi:10.1093/protein/gzz031 · Cited by 40
Kelow, S. P., Adolf‐Bryfogle, J., & Dunbrack, R. L. (2020) · mAbs · doi:10.1080/19420862.2020.1840005 · Cited by 44
Self-citationProspects of Neutralizing Nanobodies Against SARS-CoV-2
Chen, F., Liu, Z., & Jiang, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.690742 · Cited by 40
Biomedical Science to Tackle the COVID-19 Pandemic: Current Status and Future Perspectives
Zamora‐Ledezma, C., Clavijo-Calderón, D., Medina, E. A., Sinche, F. L., Vispo, N. S., Dahoumane, S. A., & Alexis, F. (2020) · Molecules · doi:10.3390/molecules25204620 · Cited by 39
Murin, C. D., Bruhn, J. F., Bornholdt, Z. A., Copps, J., Stanfield, R. L., & Ward, A. B. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.009 · Cited by 38
Applications of Machine and Deep Learning in Adaptive Immunity
Pertseva, M., Gao, B., Neumeier, D., Yermanos, A., & Reddy, S. T. (2021) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-101420-125021 · Cited by 38
A consensus protocol for the in silico optimisation of antibody fragments
Soler, M. A., Medagli, B., Semrau, M. S., Storici, P., Bajc, G., de Marco, A., Laio, A., & Fortuna, S. (2019) · Chemical Communications · doi:10.1039/c9cc06182g · Cited by 35
Kim, D. N., McNaughton, A. D., & Kumar, N. (2024) · Bioengineering · doi:10.3390/bioengineering11020185 · Cited by 35
The advent of de novo proteins for cancer immunotherapy
Quijano‐Rubio, A., Ulge, U. Y., Walkey, C., & Silva, D. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2020.02.002 · Cited by 36
Frick, R., Høydahl, L. S., Petersen, J., du Pré, M. F., Kumari, S., Berntsen, G., Dewan, A. E., Jeliazkov, J. R., Gunnarsen, K. S., Frigstad, T., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abg4925 · Cited by 32
Yang, Y. X., Wang, P., & Zhu, B. T. (2022) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2022.108364 · Cited by 31
Multistate design of influenza antibodies improves affinity and breadth against seasonal viruses
Sevy, A. M., Wu, N. C., Gilchuk, I. M., Parrish, E. H., Burger, S., Yousif, D., Nagel, M., Schey, K. L., Wilson, I. A., Crowe, J. E., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806004116 · Cited by 29
Artificial intelligence-driven computational methods for antibody design and optimization
Vecchietti, L. F., Wijaya, B. N., Armanuly, A., Hangeldiyev, B., Jung, H., Lee, S., Cha, M., & Kim, H. M. (2025) · mAbs · doi:10.1080/19420862.2025.2528902 · Cited by 32
Evolution of nanobodies specific for BCL11A
Yin, M., Izadi, M., Tenglin, K., Viennet, T., Zhai, L., Zheng, G., Arthanari, H., Dassama, L. M. K., & Orkin, S. H. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2218959120 · Cited by 28
How can we discover developable antibody-based biotherapeutics?
Bauer, J., Rajagopal, N., Gupta, P., Gupta, P. K., Nixon, A. E., & Kumar, S. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1221626 · Cited by 28
Clark, T., Subramanian, V., Jayaraman, A., Fitzpatrick, E., Gopal, R., Pentakota, N., Rurak, T. T., Anand, S., Viglione, A., Raman, R., et al. (2023) · Communications Chemistry · doi:10.1038/s42004-023-01037-7 · Cited by 27
IgGM: A Generative Model for Functional Antibody and Nanobody DesignPreprint
Wang, R., Wu, F., Gao, X., Wu, J., Zhao, P., & Yao, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.19.613838 · Cited by 27
AI-driven innovation in antibody-drug conjugate design
Noriega, H. A., & Wang, X. S. (2025) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2025.1628789 · Cited by 26
Reading the repertoire: Progress in adaptive immune receptor analysis using machine learning
O’Donnell, T. J., Kanduri, C., Isacchini, G., Limenitakis, J. P., Brachman, R. A., Alvarez, R. A., Haff, I. H., Sandve, G. K., & Greiff, V. (2024) · Cell Systems · doi:10.1016/j.cels.2024.11.006 · Cited by 24
Neamțu, A., Mocci, F., Laaksonen, A., & da Silva, F. L. B. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112986 · Cited by 23
Learned features of antibody-antigen binding affinity
Miller, N. L., Clark, T., Raman, R., & Sasisekharan, R. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1112738 · Cited by 22
Basak, S. C., Majumdar, S., Nandy, A., Roy, P., Dutta, T., Vračko, M., & Bhattacharjee, A. K. (2019) · Pharmaceuticals · doi:10.3390/ph12040157 · Cited by 22
Structure, function, and immunomodulation of the CD8 co-receptor
Srinivasan, S., Zhu, C., & McShan, A. C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1412513 · Cited by 21
Simultaneous prediction of antibody backbone and side-chain conformations with deep learning
Akpinaroglu, D., Ruffolo, J. A., Mahajan, S. P., & Gray, J. J. (2022) · PLOS ONE · doi:10.1371/journal.pone.0258173 · Cited by 21
Adaption of human antibody λ and κ light chain architectures to CDR repertoires
van der Kant, R., Bauer, J., Karow‐Zwick, A. R., Kube, S., Garidel, P., Blech, M., Rousseau, F., & Schymkowitz, J. W. H. (2019) · Protein Engineering Design and Selection · doi:10.1093/protein/gzz012 · Cited by 21
Hallucinating structure-conditioned antibody libraries for target-specific binders
Mahajan, S. P., Ruffolo, J. A., Frick, R., & Gray, J. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.999034 · Cited by 20
A suite of designed protein cages using machine learning and protein fragment-based protocols
Meador, K., Castells-Graells, R., Aguirre, R., Sawaya, M. R., Arbing, M. A., Sherman, T., Senarathne, C., & Yeates, T. O. (2024) · Structure · doi:10.1016/j.str.2024.02.017 · Cited by 19
Deep learning of protein sequence design of protein–protein interactions
Syrlybaeva, R. R., & Strauch, E. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac733 · Cited by 21
De novo design of epitope-specific antibodies via a structure-driven computational workflow
Wu, F., Zhao, Y. S., Wu, J., Jiang, B., He, B., Huang, L.-K., Qin, C., Xiao, Y., Yang, F., Wang, R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67361-9 · Cited by 18
Surface ID: a geometry-aware system for protein molecular surface comparison
Riahi, S., Lee, J. H., Sorenson, T., Wei, S., Jäger, S., Olfati‐Saber, R., Zhou, Y., Park, A., Wendt, M., Minoux, H., et al. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad196 · Cited by 18
PARCE: Protocol for Amino acid Refinement through Computational Evolution
Ochoa, R., Soler, M. A., Laio, A., & Cossio, P. (2020) · Computer Physics Communications · doi:10.1016/j.cpc.2020.107716 · Cited by 18
A comprehensive overview of recent advances in generative models for antibodies
Meng, F., Zhou, N., Guangchun, H., Liu, R., Zhang, Y., Jing, M., & Hou, Q. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.06.016 · Cited by 17
Dreyer, F. A., Schneider, C., Kovaltsuk, A., Cutting, D., Byrne, M. J., Nissley, D. A., Kenlay, H., Marks, C., Errington, D., Gildea, R. J., et al. (2025) · mAbs · doi:10.1080/19420862.2025.2511220 · Cited by 20
Cuevas, S. A. P., Etchebest, C., & da Silva, F. L. B. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00895 · Cited by 18
IsAb: a computational protocol for antibody design
Liang, T., Chen, H., Yuan, J., Jiang, C., Hao, Y., Wang, Y., Feng, Z., & Xie, X. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab143 · Cited by 17
A penultimate classification of canonical antibody CDR conformationsPreprint
Kelow, S. P., Faezov, B., Xu, Q., Parker, M. I., Adolf‐Bryfogle, J., & Dunbrack, R. L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.12.511988 · Cited by 17
Self-citationBielska, W., Jaszczyszyn, I., Dudzic, P., Janusz, B., Chomicz, D., Wrobel, S., Greiff, V., Feehan, R., Adolf‐Bryfogle, J., & Krawczyk, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1571371 · Cited by 17
Self-citationGallo, E. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01064-2 · Cited by 17
Fast and accurate modeling and design of antibody-antigen complex using tFoldPreprint
Wu, F., Zhao, Y. S., Wu, J., Jiang, B., He, B., Huang, L.-K., Qin, C., Yang, F., Huang, N., Xiao, Y., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.05.578892 · Cited by 16
Ertelt, M., Moretti, R., Meiler, J., & Schoeder, C. T. (2025) · Science Advances · doi:10.1126/sciadv.adr7338 · Cited by 15
Lauro, A. D., Rienzo, L. D., Miotto, M., Olimpieri, P. P., Milanetti, E., & Ruocco, G. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.874296 · Cited by 15
Yang, X., Duan, H., Liu, X., Zhang, X., Pan, S., Zhang, F., Gao, P., Лю, Б., Yang, J., Chi, X., et al. (2023) · Journal of Virology · doi:10.1128/jvi.00610-23 · Cited by 15
Wienke, C., Bartsch, M. V., Vogelgesang, L., Reichert, C., Hinrichs, H., Heinze, H., & Dürschmid, S. (2021) · Cerebral Cortex Communications · doi:10.1093/texcom/tgab001 · Cited by 16
Applying artificial intelligence to accelerate and de-risk antibody discovery
Musnier, A., Dumet, C., Mitra, S., Verdier, A., Keskes, R., Chassine, A., Jullian, Y., Cortès, M., Corde, Y., Omahdi, Z., et al. (2024) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2024.1339697 · Cited by 14
NanoBinder: a machine learning assisted nanobody binding prediction tool using Rosetta energy scores
Shrestha, P., Talwar, C. S., Kandel, J., Park, K., Chong, K. T., Woo, E., & Tayara, H. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-01040-1 · Cited by 14
Non-H3 CDR template selection in antibody modeling through machine learning
Long, X., Jeliazkov, J. R., & Gray, J. J. (2019) · PeerJ · doi:10.7717/peerj.6179 · Cited by 14
Zhao, W., Luo, X., Tong, F., Zheng, X., Li, J., Zhao, G., & Zhao, D. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.11.041 · Cited by 13
AbFlex: designing antibody complementarity determining regions with flexible CDR definition
Jeon, W., & Kim, D. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae122 · Cited by 14
Improved HIV-1 neutralization breadth and potency of V2-apex antibodies by in silico design
Holt, G. T., Gorman, J., Wang, S., Lowegard, A. U., Zhang, B., Liu, T. W. B., Lin, B. C., Louder, M. K., Frenkel, M. S., McKee, K., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112711 · Cited by 13
Exploring Log-Likelihood Scores for Ranking Antibody Sequence DesignsPreprint
Uçar, T., Malherbe, C., & Hernandez, F. G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.07.617023 · Cited by 16
Ghosh, I., Miranda, D., Kulkarni, T. A., Deodhar, S., Tummala, S., & Bindra, D. S. (2025) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2025.103914 · Cited by 12
Flow matching meets biology and life science: a survey
Li, Z., Zeng, Z., Lin, X., Fang, F., Qu, Y., Xu, Z., Liu, Z., Ning, X., Wei, T., Liu, G., et al. (2026) · npj Artificial Intelligence · doi:10.1038/s44387-025-00066-y · Cited by 21
Computer‐based engineering of thermostabilized antibody fragments
Lee, J., Der, B. S., Karamitros, C. S., Li, W., Marshall, N., Lungu, O. I., Miklos, A. E., Xu, J., Kang, T. H., Lee, C., et al. (2019) · AIChE Journal · doi:10.1002/aic.16864 · Cited by 12
Sueiras, M., Thonon, V., Santamarina, E., Sánchez-Guerrero, Á., Riveiro, M., Poca, M. A., Quintana, M., Gándara, D., & Sahuquillo, J. (2020) · Neurocritical Care · doi:10.1007/s12028-020-01107-x · Cited by 12
Bonadio, A., & Shifman, J. M. (2021) · Protein Engineering Design and Selection · doi:10.1093/protein/gzab020 · Cited by 12
Schmitz, S., Soto, C. S., Crowe, J. E., & Meiler, J. (2020) · mAbs · doi:10.1080/19420862.2020.1758291 · Cited by 12
End-to-End deep structure generative model for protein designPreprint
Lai, B., McPartlon, M., & Xu, J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.09.499440 · Cited by 12
Incorporating Pre-training Paradigm for Antibody Sequence-Structure Co-designPreprint
Gao, K., Wu, L., Zhu, J., Peng, T., Xia, Y., He, L., Xie, S., Qin, T., Liu, H., He, K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.14.516404 · Cited by 13
FlowDesign: Improved design of antibody CDRs through flow matching and better prior distributions
Wu, J., Kong, X., Sun, N., Wei, J., Shan, S., Feng, F., Wu, F., Peng, J., Zhang, L., Liu, Y., et al. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101270 · Cited by 11
Prediction of antibody-antigen interaction based on backbone aware with invariant point attention
Gu, M., Yang, W., & Liu, M. (2024) · BMC Bioinformatics · doi:10.1186/s12859-024-05961-w · Cited by 11
Su, C., He, J., Xie, Y., Hu, Y., Li, X., Qiao, S., Liu, P., Huang, M., Zhang, R., Wang, L., et al. (2025) · hLife · doi:10.1016/j.hlife.2024.12.006 · Cited by 11
Complexity of Viral Epitope Surfaces as Evasive Targets for Vaccines and Therapeutic Antibodies
Miller, N. L., Raman, R., Clark, T., & Sasisekharan, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.904609 · Cited by 12
Villegas-Morcillo, A., Weber, J. M., & Reinders, M. J. T. (2024) · PRX Life · doi:10.1103/prxlife.2.033012 · Cited by 11
GlycoSHIELD: a versatile pipeline to assess glycan impact on protein structuresPreprint
Gecht, M., von Bülow, S., Penet, C., Hummer, G., Hanus, C., & Sikora, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.04.455134 · Cited by 12
Yin, M., Zhou, H., Wu, J., Zhu, Y., Zhan, Y., Kong, Z., Xu, H., Hsieh, C., Chen, J., Hou, T., et al. (2025) · Research · doi:10.34133/research.0721 · Cited by 12
Metadata
- Authors
- Adolf-Bryfogle, J., Kalyuzhniy, O., Kubitz, M., Weitzner, B. D., Hu, X., Adachi, Y., Schief, W. R., & Dunbrack, R. L.
- Affiliations
- Scripps Research Institute (US)
- University of Washington (US)
- Fox Chase Cancer Center (US)
- Corresponding author
- Dunbrack, Roland L.
- ORCID
- Venue
- PLoS Computational Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-04-27
- Volume
- 14
- Issue
- 4
- Pages
- e1006112
- ISSN
- 1553-734X (ISSN-L)
- 1553-7358
- PMC
- PMC5942852
- OpenAlex
- W2953176058
- Cited by
- 227
- References
- 120
- Citations by year
- 2026: 29 · 2025: 46 · 2024: 42 · 2023: 30 · 2022: 25 · 2021: 21 · 2020: 16 · 2019: 13 · 2018: 5
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Update notices
- new_version (2018-05-09)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Computational Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute of General Medical Sciences (R35 GM122517, R01 GM111819)
- National Institute of Allergy and Infectious Diseases (P01 AI094419)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Keywords
- computational antibody design, CDR grafting, sequence design, antibody-antigen interface, immune complexes, sequence profiles, epitope mapping
- MeSH terms
- Amino Acid Sequence, Animals, Antibodies, Antigen-Antibody Complex, Computer Simulation, Humans, Models, Molecular, Monte Carlo Method, Protein Conformation, Software, Drug Design, Protein Engineering, Directed Molecular Evolution, Computational Biology, Complementarity Determining Regions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
